Company sells common shares with four-year warrants at $0.50 per unit
By Devika Patel
Knoxville, Tenn., Oct. 11 - AtheroNova Inc. said it settled a $2.93 million private placement of units with a $425,000 tranche. The deal was announced Oct. 5, when the company announced it raised $2.5 million on Oct. 1.
The company sold 5.85 million units of one common share and a half-share warrant at $0.50 per unit. It sold 5 million units in the initial tranche and 850,000 units in the second.
The whole warrants are each exercisable at $0.625 for four years. The strike price is a 23.78% discount to the Sept. 28 closing share price of $0.82.
AtheroNova is a Van Nuys, Calif., development stage company that is developing products to address the treatment of atherosclerosis through the use of natural compounds and their derivatives.
| Issuer: | AtheroNova Inc.
|
| Issue: | Units of one common share and a half-share warrant
|
| Amount: | $2,925,000
|
| Units: | 5.85 million
|
| Price: | $0.50
|
| Warrants: | One half-share warrant per unit
|
| Warrant expiration: | Four years
|
| Warrant strike price: | $0.625
|
| Settlement date: | Oct. 1 (for $2.5 million), Oct. 11 (for $425,000)
|
| Stock symbol: | OTCBB: AHRO
|
| Stock price: | $0.82 at close Sept. 28
|
| Market capitalization: | $21.45 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
